TrialClinical and translational science2023

Bioequivalence study of dacomitinib and Vizimpro® in healthy Chinese volunteers under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.

Xiaojia Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.